Microsoft Word 88 Hemofiliya

Br J Haematol 1992; 82(1):87-93. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/1419807?dopt=Abstract  (20.10.2014) 

48.

 

Mannucci PM. Hemostatic drugs. [Electronic resource]. N Engl J Med 

1998 Jul 23; 339(4):245-53. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/9673304?dopt=Abstract  (20.10.2014) 

49.

 

Mannucci PM, Gringeri A, Savidge G, et al; European- Australian 

Haemophilia Collaborative Study Group. Randomized double-blind, 

placebo-controlled trial of twice-daily zidovudine in asymptomatic 

hemophiliacs. [Electronic resource]. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/7912097?dopt=Abstract  (20.10.2014) 

50.

 

Mannucci PM. Use of desmopressin (DDAVP) during early pregnancy 

in factor VIII-deficient women. Blood 2005; 105(8):3382. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/15802549 (20.10.2014) 

51.

 

Martinowitz U, Luboshitz J, Bashari D, et al. Stability, efficacy, and 

safety of continuously infused sucrose-formulated recombinant factor 

VIII (rFVIII-FS) during surgery in patients with severe haemophilia. 

[Electronic resource]. Haemophilia 2009; 15(3):676-85. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/19298381?dopt=Abstract (20.10.2014) 

52.

 

Meijer P, Verbruggen B. The between-laboratory variation of factor 

VIII inhibitor testing: the experience of the external quality assessment 

program of the ECAT foundation. [Electronic resource]. Semin Thromb 

Hemost 2009; 35(8):786-93. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/20169515?dopt=Abstract (20.10.2014) 

53.

 

Mortazavi SM, Heidari P. Retrograde intramedullary nailing of 

supracondylar femoral fractures in haemophilic patients. [Electronic 

resource].  Haemophilia  2008; 14(3):661-664. - Available at: 

 

http://www.ncbi.nlm.nih.gov/pubmed/18397284?dopt=Abstract (20.10.2014) 

54.

 

Neunert CE, Miller KL, Journeycake JM, et al. Implantable central 

venous access device procedures in haemophilia patients without an 

inhibitor: systematic review of the literature and institutional 

experience. [Electronic resource]. Haemophilia  2008; 14(2):260-70. - 

Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/18179577?dopt=Abstract (20.10.2014) 

55.

 

Operskalski EA, Kovacs A. HIV/HCV co-infection: pathogenesis, 

clinical complications, treatment, and new therapeutic technologies. 

 

 

 

 

 

 

Klinik protokol Az

ərbaycan Respublikas

ı S

əhiyy

ə Nazirliyinin 

İctimai S

əhi

yy

ə v

ə 

İslahatlar M

ərk

əzind

ə haz

ırlanm

ış

dı

r. 

---

60 

[Electronic resource]. Curr HIV/AIDS Rep 2011 Mar; 8(1):12-22. - 

Available at: 

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035774/  (20.10.2014) 

56.

 

Petrini P, Seuser A. Haemophilia care in adolescents – compliance and 

lifestyle issues. [Electronic resource]. Haemophilia  2009; 15 Suppl 

1:15-9.- Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/19125936?dopt=Abstract  (20.10.2014)  

57.

 

Quon DV, Konkle BA. How we treat haematuria in adults with 

haemophilia. [Electronic resource]. Haemophilia  2010; 16(4):683-5. - 

Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/20041958?dopt=Abstract  (20.10.2014) 

58.

 

Ragni MV, Journeycake JM, Brambilla DJ. Tissue plasminogen 

activator to prevent central venous access device infections: a 

systematic review of central venous access catheter thrombosis, 

infection and thromboprophylaxis. [Electronic resource]. Haemophilia 

2008; 14(1):30-8.- Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/18005145?dopt=Abstract  (20.10.2014)  

59.

 

Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of 

haemophilic synovitis, target joints, and pain in adults and children 

with haemophilia. [Electronic resource]. Haemophilia 2006; 12(5):514-

7. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/16919082?dopt=Abstract  (20.10.2014) 

60.

 

Recht M, Pollmann H, Tagliaferri A, et al. A retrospective study to 

describe the incidence of moderate to severe allergic reactions to factor 

IX in subjects with haemophilia B. [Electronic resource]. Haemophilia 

2011; 17(3):494-9. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/21518148?dopt=Abstract (20.10.2014) 

61.

 

Rodriguez-Merchan EC. Aspects of current management: orthopaedic 

surgery in haemophilia. [Electronic resource]. Haemophilia  2012; 

18(1):8-16. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/21535324?dopt=Abstract (20.10.2014) 

62.

 

Rodriguez-Merchan EC. Bone fractures in the haemophilia patient. 

[Electronic resource]. Haemophilia 2002; 8(2):104-11. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/11952845?dopt=Abstract (20.10.2014) 

63.

 

Ruiz-Sáez A, Hong A, Arguello A, Echenagucia M, Boadas A, 

Fabbrizzi F, Minichilli F, Bosch NB. Pharmacokinetics, 

thrombogenicity and safety of a double viral inactivated factor IX 

 

 

 

 

 

 

Klinik protokol Az

ərbaycan Respublikas

ı S

əhiyy

ə Nazirliyinin 

İctimai S

əhi

yy

ə v

ə 

İslahatlar M

ərk

əzind

ə haz

ırlanm

ış

dı

r. 

---

61 

concentrate compared with a prothrombin complex concentrate. 

[Electronic resource]. Haemophilia 2005; 11(6):583-8. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/16236107?dopt=Abstract (20.10.2014) 

64.

 

Santagostino E, Colombo M, Rivi M, et al. A 6-month versus a 12-

month surveillance for hepatocellular carcinoma in 559 hemophiliacs 

infected with the hepatitis C virus. [Electronic resource]. Blood 2003; 

102(1):78-82. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/12649165 (20.10.2014) 

65.

 

Schild FJ, Mauser-Bunschoten EP, Verbout AJ, Van Rinsum AC, 

Roosendaal G. Total knee arthroplasty in hemophilic arthropathy: 

efficiency of clotting factor usage in multijoint procedures. [Electronic 

resource]. J Thromb Haemost 2009; 7(10):1741-3. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/19682237?dopt=Abstract (20.10.2014) 

66.

 

Seuser A, Boehm P, Kurme A, Schumpe G, Kurnik K. Orthopaedic 

issues in sports for persons with haemophilia. [Electronic resource].